A detailed history of Sage View Advisory Group, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Sage View Advisory Group, LLC holds 9,711 shares of BSX stock, worth $978,189. This represents 0.04% of its overall portfolio holdings.

Number of Shares
9,711
Previous 9,261 4.86%
Holding current value
$978,189
Previous $776 Million 11.76%
% of portfolio
0.04%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$83.62 - $91.5 $37,629 - $41,175
450 Added 4.86%
9,711 $867 Million
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $18,896 - $21,756
259 Added 2.88%
9,261 $776 Million
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $55,210 - $63,722
820 Added 10.02%
9,002 $693 Million
Q1 2024

May 08, 2024

SELL
$57.6 - $68.62 $80,409 - $95,793
-1,396 Reduced 14.58%
8,182 $560 Million
Q4 2023

Feb 09, 2024

BUY
$48.64 - $57.81 $465,873 - $553,704
9,578 New
9,578 $588 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $144B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Sage View Advisory Group, LLC Portfolio

Follow Sage View Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage View Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage View Advisory Group, LLC with notifications on news.